News Conference News AHA 2022 Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION Michael O'Riordan November 09, 2022
News Conference News AHA 2022 Etripamil Nasal Spray in Paroxysmal SVT Speeds Conversion to Sinus Rhythm: RAPID Shelley Wood November 07, 2022
News Conference News AHA 2022 Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study Michael O'Riordan November 07, 2022
News Daily News Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT Todd Neale November 01, 2022
News Daily News RAPID: Positive Top-line Results for Etripamil Nasal Spray in Paroxysmal SVT Todd Neale October 17, 2022
News Conference News TCT 2022 Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes Todd Neale September 22, 2022
News Daily News AI Tool Can Quantify CAC—and Associated CV Risk—From PET Yael L. Maxwell September 14, 2022
News Daily News New on the Scene Nonstatin Drugs: Experts Provide Guidance Caitlin E. Cox August 31, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Daily News New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill Shelley Wood August 23, 2022
News Daily News Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis Yael L. Maxwell August 16, 2022
News Daily News AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data Yael L. Maxwell August 12, 2022
News Daily News Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression Michael O'Riordan August 08, 2022
News Daily News Certain CV Meds Tied to Higher MI Risk in Warmer Weather Caitlin E. Cox August 04, 2022
News Daily News Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained Yael L. Maxwell July 15, 2022
News Daily News Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes Todd Neale July 04, 2022
News Daily News Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach Michael O'Riordan June 21, 2022
News Daily News Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women Yael L. Maxwell June 03, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022